Outset Medical Shares Sink After Cutting Outlook

Dow Jones11-11

By Connor Hart

Shares of Outset Medical fell after the company cut its full-year outlook after missing out on some expected sales during the third quarter.

The stock declined 26% to $8.93 in premarket trading Tuesday. Through Monday's close, shares have lost nearly 28% of their value so far this year.

The medical technology company late Monday said it now expects full-year revenue of $115 million to $120 million, down from a prior range of $122 million to $126 million. Analysts polled by FactSet had been expecting revenue of $124.1 million for the year.

Outset Medical continues to expect adjusted gross margins in the high-30% range. The company said it expects to use less than $50 million of cash in 2025, compared with over $100 million used last year.

Chief Executive Leslie Trigg said the expected timing to close "several large opportunities forecasted for the second half of 2025 has shifted."

"These opportunities remain in the final stages of our sales process and are now expected to close over the fourth quarter and into early 2026," she added.

For its three months ended Sept. 30, Outset Medical posted a net loss of $17.8 million, or $1 a share, compared with a loss of $27.9 million, or $8.02 a share, a year earlier.

On an adjusted basis, the company's net loss was 69 cents a share. Analysts were looking for an adjusted loss of 66 cents a share.

Revenue edged up 2.7% to $29.4 million but missed the $30.7 million that Wall Street modeled.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

November 11, 2025 06:32 ET (11:32 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2582363131?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-11 19:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582363131","market":"hk","top_or_hot":-1,"title":"Outset Medical Shares Sink After Cutting Outlook","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Outset Medical fell after the company cut its full-year outlook after missing out on some expected sales during the third quarter. \n</p>\n<p>\n  The stock declined 26% to $8.93 in premarket trading Tuesday. Through Monday's close, shares have lost nearly 28% of their value so far this year. \n</p>\n<p>\n  The medical technology company late Monday said it now expects full-year revenue of $115 million to $120 million, down from a prior range of $122 million to $126 million. Analysts polled by FactSet had been expecting revenue of $124.1 million for the year. \n</p>\n<p>\n  Outset Medical continues to expect adjusted gross margins in the high-30% range. The company said it expects to use less than $50 million of cash in 2025, compared with over $100 million used last year. \n</p>\n<p>\n  Chief Executive Leslie Trigg said the expected timing to close \"several large opportunities forecasted for the second half of 2025 has shifted.\" \n</p>\n<p>\n  \"These opportunities remain in the final stages of our sales process and are now expected to close over the fourth quarter and into early 2026,\" she added. \n</p>\n<p>\n  For its three months ended Sept. 30, Outset Medical posted a net loss of $17.8 million, or $1 a share, compared with a loss of $27.9 million, or $8.02 a share, a year earlier. \n</p>\n<p>\n  On an adjusted basis, the company's net loss was 69 cents a share. Analysts were looking for an adjusted loss of 66 cents a share. \n</p>\n<p>\n  Revenue edged up 2.7% to $29.4 million but missed the $30.7 million that Wall Street modeled. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 11, 2025 06:32 ET (11:32 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Outset Medical Shares Sink After Cutting Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOutset Medical Shares Sink After Cutting Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-11 19:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Outset Medical fell after the company cut its full-year outlook after missing out on some expected sales during the third quarter. \n</p>\n<p>\n  The stock declined 26% to $8.93 in premarket trading Tuesday. Through Monday's close, shares have lost nearly 28% of their value so far this year. \n</p>\n<p>\n  The medical technology company late Monday said it now expects full-year revenue of $115 million to $120 million, down from a prior range of $122 million to $126 million. Analysts polled by FactSet had been expecting revenue of $124.1 million for the year. \n</p>\n<p>\n  Outset Medical continues to expect adjusted gross margins in the high-30% range. The company said it expects to use less than $50 million of cash in 2025, compared with over $100 million used last year. \n</p>\n<p>\n  Chief Executive Leslie Trigg said the expected timing to close \"several large opportunities forecasted for the second half of 2025 has shifted.\" \n</p>\n<p>\n  \"These opportunities remain in the final stages of our sales process and are now expected to close over the fourth quarter and into early 2026,\" she added. \n</p>\n<p>\n  For its three months ended Sept. 30, Outset Medical posted a net loss of $17.8 million, or $1 a share, compared with a loss of $27.9 million, or $8.02 a share, a year earlier. \n</p>\n<p>\n  On an adjusted basis, the company's net loss was 69 cents a share. Analysts were looking for an adjusted loss of 66 cents a share. \n</p>\n<p>\n  Revenue edged up 2.7% to $29.4 million but missed the $30.7 million that Wall Street modeled. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 11, 2025 06:32 ET (11:32 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OM","symbol_name":"Outset Medical Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2582363131","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582363131","pubTimestamp":1762860720,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Outset Medical fell after the company cut its full-year outlook after missing out on some expected sales during the third quarter.The stock declined 26% to $8.93 in premarket trading Tuesday. Through Monday's close, shares have lost nearly 28% of their value so far this year.The medical technology company late Monday said it now expects full-year revenue of $115 million to $120 million, down from a prior range of $122 million to $126 million. Analysts polled by FactSet had been expecting revenue of $124.1 million for the year.Outset Medical continues to expect adjusted gross margins in the high-30% range. The company said it expects to use less than $50 million of cash in 2025, compared with over $100 million used last year.Chief Executive Leslie Trigg said the expected timing to close \"several large opportunities forecasted for the second half of 2025 has shifted.\". \"These opportunities remain in the final stages of our sales process and are now expected to close over the fo","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OM":"Outset Medical Inc.","BK4082":"医疗保健设备"},"translate_title":"Outset Medical股价在下调前景后下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OM":1.5},"content_text":"By Connor Hart \n\n\n \n\n\n  Shares of Outset Medical fell after the company cut its full-year outlook after missing out on some expected sales during the third quarter. \n\n\n  The stock declined 26% to $8.93 in premarket trading Tuesday. Through Monday's close, shares have lost nearly 28% of their value so far this year. \n\n\n  The medical technology company late Monday said it now expects full-year revenue of $115 million to $120 million, down from a prior range of $122 million to $126 million. Analysts polled by FactSet had been expecting revenue of $124.1 million for the year. \n\n\n  Outset Medical continues to expect adjusted gross margins in the high-30% range. The company said it expects to use less than $50 million of cash in 2025, compared with over $100 million used last year. \n\n\n  Chief Executive Leslie Trigg said the expected timing to close \"several large opportunities forecasted for the second half of 2025 has shifted.\" \n\n\n  \"These opportunities remain in the final stages of our sales process and are now expected to close over the fourth quarter and into early 2026,\" she added. \n\n\n  For its three months ended Sept. 30, Outset Medical posted a net loss of $17.8 million, or $1 a share, compared with a loss of $27.9 million, or $8.02 a share, a year earlier. \n\n\n  On an adjusted basis, the company's net loss was 69 cents a share. Analysts were looking for an adjusted loss of 66 cents a share. \n\n\n  Revenue edged up 2.7% to $29.4 million but missed the $30.7 million that Wall Street modeled. \n\n\n \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 11, 2025 06:32 ET (11:32 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2582363131","isCrawlerRequest":true}